Starpharma Holdings Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Starpharma Holdings Limited with three other companies in this sector in Australia: Oncosil Medical Ltd (2017 sales of 3.76 million Australian Dollars [US$2.92 million] ), Mesoblast Ltd (3.20 million Australian Dollars [US$2.49 million] of which 100% was Mesenchymal Precursor Cell), and Dorsavi Ltd (3.87 million Australian Dollars [US$3.01 million] of which 53% was Australia).

Sales Analysis. During the year ended June of 2017, sales at Starpharma Holdings Limited were A$3.65 million (US$2.84 million). This is a decrease of 21.3% versus 2016, when the company's sales were A$4.63 million.